NordicInfu Care AB Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • NordicInfu Care AB's estimated annual revenue is currently $53M per year.(i)
  • NordicInfu Care AB's estimated revenue per employee is $251,000

Employee Data

  • NordicInfu Care AB has 211 Employees.(i)
  • NordicInfu Care AB grew their employee count by 6% last year.

NordicInfu Care AB's People

NameTitleEmail/Phone
1
Head Regulatory, QA and PVReveal Email/Phone
2
Nordic Business Unit & External Affairs DirectorReveal Email/Phone
3
Associate Director, AccountingReveal Email/Phone
4
Quality & Regulatory Affairs Manager MedtechReveal Email/Phone
5
Key Account ManagerReveal Email/Phone
6
Key Account Manager NeurologyReveal Email/Phone
7
Key Account Manager, NeurologyReveal Email/Phone
8
Nordic Customer Experience Manager NeurologyReveal Email/Phone
9
Key Account ManagerReveal Email/Phone
10
Key Account ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.1M49-18%$10MN/A
#2
$30.4M12129%N/AN/A
#3
$139.8M913-3%$200KN/A
#4
$84.1M0N/A$1.2MN/A
#5
$43.4M17330%N/AN/A
#6
$64.5M25712%N/AN/A
#7
$64.3M20526%$129.6MN/A
#8
$19.6M78-7%N/AN/A
#9
$65.8M2627%N/AN/A
#10
$73.7M23520%$115.5MN/A
Add Company

What Is NordicInfu Care AB?

See www.infucare.com

keywords:N/A

N/A

Total Funding

211

Number of Employees

$53M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NordicInfu Care AB News

2019-03-26 - Anders Bodin Fastigheter hyr ut vid Alviks torg

Via två avtal har Anders Bodin hyrt ut drygt 1.100 kvm i sina fastigheter vid Alviks Torg, Stockholm. NordicInfu Care har tecknat ett 6-årigt avtal ...

2018-10-08 - TFS Collaboration with Lobsor Pharmaceuticals AB, on the ...

It is a fully owned subsidiary to Lobsor Holding AB. Lobsor has signed a collaboration agreement with NordicInfu Care for market insights in the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$62.7M21123%N/A
#2
$67.3M211-6%N/A
#3
$67.3M2113%N/A
#4
$16.2M21134%N/A
#5
$7.5M211-11%N/A